November 2014

Cost effectiveness analyses of influenza A (H1N1) vaccination programs: How accurate were they?

Three economic evaluations of pandemic influenza A (H1N1) vaccination campaigns in North America concluded that the mass vaccination campaigns would be, or were, highly cost-effective, if not cost-saving. This paper re-assesses each study's analysis and presents three arguments: 1) prediction of vaccine program cost-effectiveness is unrealistic, if not impossible, unless quality surveillance data is available; 2)...

Author(s): Michael F. Beeler, Dionne M. Aleman and Michael W. Carter